Literature DB >> 12079913

Peptostreptococcal pericarditis complicating anti-tumour necrosis factor alpha treatment in rheumatoid arthritis.

S Harney, F D O'Shea, O FitzGerald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12079913      PMCID: PMC1754167          DOI: 10.1136/ard.61.7.653

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 2.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

3.  Complication of etanercept treatment for rheumatoid arthritis--purulent pericarditis caused by a commensal organism.

Authors:  Gemma K Taylor; Louise Elliott; Michael D Sosin; Shiu Shing Soo
Journal:  BMJ Case Rep       Date:  2012-05-08

Review 4.  Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: update on safety in older patients.

Authors:  Paul Ornetti; Hélène Chevillotte; Amal Zerrak; Jean Francis Maillefert
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Infliximab-Induced Lupus Causing Pericarditis: a Case Report and Review of the Literature.

Authors:  Mrudula Thiriveedi; Taylor D Steuber; Mohamed Hasan; Alan Baggett
Journal:  J Gen Intern Med       Date:  2021-04-14       Impact factor: 6.473

6.  Hemorrhagic Pericardial Effusion with Tamponade: A Rare Adverse Effect of Infliximab-Case Report and Literature Review.

Authors:  Henry D Lather; J Michelle Kahlenberg
Journal:  Case Rep Rheumatol       Date:  2016-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.